| Symbol | FBRX |
|---|---|
| Name | FORTE BIOSCIENCES, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 3060 PEGASUS PARK DRIVE,BUILDING 6, DALLAS, Texas, 75247, United States |
| Telephone | +1 310 618-6994 |
| Fax | — |
| — | |
| Website | https://www.fortebiorx.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001419041 |
| Description | Forte Biosciences Inc is a clinical-stage biopharmaceutical company, focused on dermatology. The company is developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric patients with atopic dermatitis. It plans to advance FB-401 into a randomized Phase 2 clinical trial. Additional info from NASDAQ: |
2026-04-29 17:09
New Form ARS - Forte Biosciences, Inc. <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 0001193125-26-191537 <b>Size:</b> 621 KB
Read more
2026-04-09 17:13
New Form 424B5 - Forte Biosciences, Inc. <b>Filed:</b> 2026-04-09 <b>AccNo:</b> 0001193125-26-149630 <b>Size:</b> 484 KB
Read more
2026-04-09 01:30
Forte Biosciences Inc - Forte Biosciences Announces Pricing of $150 Million Public Offering
Read more
2026-04-08 20:02
Forte Biosciences Inc - Forte Biosciences Announces Proposed Public Offering
Read more
2026-04-08 17:22
New Form 424B5 - Forte Biosciences, Inc. <b>Filed:</b> 2026-04-08 <b>AccNo:</b> 0001193125-26-147698 <b>Size:</b> 485 KB
Read more
2026-04-03 20:02
Riley Antony A 🟡 adjusted position in 134 shares (1 derivative) of Forte Biosciences, Inc. (FBRX) at $24.86 Transaction Date: Apr 01, 2026 | Filing ID: 000006
Read more
2026-04-03 20:01
Wagner Paul A. 🟡 adjusted position in 98 shares (1 derivative) of Forte Biosciences, Inc. (FBRX) at $24.86 Transaction Date: Apr 01, 2026 | Filing ID: 000006
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07081737 | Person-Centred AI Support in Interdisciplinary Rehabilitation for Chronic Pain | Na | Pain, Chronic | Not_Yet_Recruiting | 2026-05-01 | 2029-03-31 | ClinicalTrials.gov |
| NCT07407946 | Blended Trauma-Focused Cognitive Behavioral Therapy With Compassion | Na | Post-traumatic Stress Disorder (PTSD) | Recruiting | 2026-02-23 | 2029-12-31 | ClinicalTrials.gov |
| NCT07205159 | A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to… | Phase1 | Alopecia Areata | Recruiting | 2025-10-23 | 2027-03-10 | ClinicalTrials.gov |
| NCT07240363 | First Line Surgery or First Line Fertility Treatment Using Assisted Reproductiv… | Na | Endometriosis | Recruiting | 2025-10-06 | 2031-09-22 | ClinicalTrials.gov |
| NCT07469917 | Safety Planning Intervention in Swedish Healthcare: A Multisite Study for Suici… | Na | Suicide Attempt | Recruiting | 2025-10-01 | 2029-07-01 | ClinicalTrials.gov |
| NCT06982963 | Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celia… | Phase2 | Celiac Disease | Recruiting | 2025-08-04 | 2027-02-28 | ClinicalTrials.gov |
| NCT06798597 | Health4Life a Digital Intervention to Promote Healthy Lifestyle Behaviours From… | Na | Healthy | Recruiting | 2025-04-01 | 2027-07-31 | ClinicalTrials.gov |
| NCT06905873 | A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segme… | Phase1 | Vitiligo | Recruiting | 2025-03-25 | 2026-12-31 | ClinicalTrials.gov |
| NCT06749080 | ASSIST 2.0: a Reablement Program for Healthy Ageing | Na | Reablement | Recruiting | 2025-02-03 | 2028-09-01 | ClinicalTrials.gov |
| NCT06752304 | A Longitudinal Study of Severe and Enduring Eating Disorders | — | Eating Disorders | Recruiting | 2024-09-01 | 2048-12-01 | ClinicalTrials.gov |
| NCT06368674 | Bridging the Gap: Creating a Continuum of Care | Na | Frailty | Recruiting | 2024-06-06 | 2027-02-01 | ClinicalTrials.gov |
| NCT06592963 | Unfolding Severe and Enduring Eating Disorders (U-SEED) | — | Eating Disorders | Recruiting | 2024-06-01 | 2026-04-01 | ClinicalTrials.gov |
| NCT06341751 | Psychological Treatment for Persistent Fatigue | Na | Fatigue | Completed | 2024-04-11 | 2025-01-15 | ClinicalTrials.gov |
| NCT05983705 | The Effect and Experience of the Parental Program AFFEKT | Na | Behavior, Child | Completed | 2023-08-23 | 2025-10-30 | ClinicalTrials.gov |
| NCT04336553 | Social Prescribing in Sweden (SPiS) | Na | Loneliness | Unknown | 2023-05-01 | 2025-12-31 | ClinicalTrials.gov |
| NCT04245384 | Dietitian Online - Internet-based Dietetic Treatment Within Health Care Services | Na | Overweight and Obesity | Unknown | 2023-03-01 | 2024-12-01 | ClinicalTrials.gov |
| NCT05646589 | A Person-centred Care Transition Support for People With Stroke/TIA | Na | Stroke | Completed | 2022-11-21 | 2025-09-15 | ClinicalTrials.gov |
| NCT05521646 | Implementing Best Practice Postpartum Contraceptive Services Through a Quality … | Na | Contraception | Unknown | 2022-09-05 | 2025-09-01 | ClinicalTrials.gov |
| NCT05279508 | Make My Day - a Stroke Prevention Program | Na | Stroke | Completed | 2022-04-09 | 2024-05-08 | ClinicalTrials.gov |
| NCT05365919 | Family Talk Intervention in the Context of Specialised Palliative Home Care | Na | Terminal Illness | Unknown | 2022-04-01 | 2024-12-31 | ClinicalTrials.gov |
| NCT05580549 | Prevalence of Hazardous Alcohol Use in a Population With Hypertension in Primar… | — | Hypertension | Unknown | 2022-03-01 | 2023-12-31 | ClinicalTrials.gov |
| NCT04317716 | A Self-management Program to Prevent Falls in People With Multiple Sclerosis | Na | Multiple Sclerosis | Completed | 2022-02-11 | 2022-08-17 | ClinicalTrials.gov |
| NCT04936113 | Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Ye… | Phase2 | Atopic Dermatitis | Terminated | 2021-06-02 | 2021-09-30 | ClinicalTrials.gov |
| NCT04351178 | F@ce 2.0 - Information and Communication Technology-based Rehabilitation Interv… | Na | Stroke | Completed | 2021-02-11 | 2023-04-28 | ClinicalTrials.gov |
| NCT05940168 | Internet-delivered ACT (I-Navigator ACT) for Parents of Children With Disabilit… | Na | Parents | Unknown | 2021-02-01 | 2023-11-30 | ClinicalTrials.gov |
| NCT04504279 | Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) Wi… | Phase2 | Atopic Dermatitis | Completed | 2020-10-13 | 2021-08-19 | ClinicalTrials.gov |
| NCT04085926 | Sealed Therapeutic Shoe as Treatment of Diabetic Foot Ulcers | Na | Diabetic Foot | Terminated | 2020-01-16 | 2022-02-01 | ClinicalTrials.gov |
| NCT04147039 | A Mobile Phone App to Promote Healthy Diet and Physical Activity in 2.5-year-ol… | Na | Obesity, Childhood | Completed | 2019-11-02 | 2022-04-08 | ClinicalTrials.gov |
| NCT04465435 | Sustainable UNiversity Life (SUN) Study | — | Mental Health Issue | Active_Not_Recruiting | 2019-08-19 | 2032-01-31 | ClinicalTrials.gov |
| NCT03729336 | PEEZY Midstream Urine Device Compared to Catheterized Urine Sample | Na | Lower Urinary Tract Symptoms | Completed | 2019-02-06 | 2019-06-01 | ClinicalTrials.gov |
| NCT03821116 | Milk and Soured Milk (filmjölk) Intervention on Oxidative Stress and Inflammati… | Na | Oxidative Stress | Completed | 2019-01-07 | 2020-06-09 | ClinicalTrials.gov |
| NCT04260672 | Child-Centred Health Dialogue in Child Health Services | Na | Child, Only | Completed | 2017-01-01 | 2021-12-31 | ClinicalTrials.gov |
| NCT02823795 | The Supporting Patient Activation in Transition to Home Intervention | Na | Medication Adherence | Completed | 2016-09-01 | 2018-09-01 | ClinicalTrials.gov |
| NCT02916849 | A Feasibility Study of a Mobile Application Intervention to Promote Strength an… | Na | Accidental Falls | Completed | 2016-09-01 | 2017-03-31 | ClinicalTrials.gov |
| NCT03131609 | Avoiding Bacterial Contamination of Clean Catch Urine Cultures in Ambulatory Pa… | — | Urinary Tract Infections | Completed | 2015-09-01 | 2016-09-01 | ClinicalTrials.gov |
| NCT05809479 | NICE - Nutritional Impact on Immunological Maturation During Childhood in Relat… | — | Chronic Diseases in Children | Active_Not_Recruiting | 2015-06-01 | 2030-06-01 | ClinicalTrials.gov |
| NCT04598373 | Effects of Interdisciplinary Treatment on Sickness Absence in Patients With Chr… | — | Chronic Pain | Completed | 2009-01-01 | 2016-12-01 | ClinicalTrials.gov |
Total clinical trials: 37
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Traditional dietetic treatment | Drug | Approved | Overweight and Obesity | UNKNOWN | NCT04245384 |
| Internet-based dietetic treatment with video calls | Drug | Approved | Overweight and Obesity | UNKNOWN | NCT04245384 |
| OEP | Other | Approved | Accidental Falls | COMPLETED | NCT02916849 |
| Safe Step | Other | Approved | Accidental Falls | COMPLETED | NCT02916849 |
| Catheter for urine collection | Other | Approved | Lower Urinary Tract Symptoms | COMPLETED | NCT03729336 |
| Midstream urine collection device | Device | Approved | Lower Urinary Tract Symptoms | COMPLETED | NCT03729336 |
| Castile-soap wipe | Other | Preclinical | Urinary Tract Infections | COMPLETED | NCT03131609 |
| Funnel | Other | Preclinical | Urinary Tract Infections | COMPLETED | NCT03131609 |
| Silver Impregnated Wipe | Other | Preclinical | Urinary Tract Infections | COMPLETED | NCT03131609 |
| Container | Other | Preclinical | Urinary Tract Infections | COMPLETED | NCT03131609 |
| Motivational Interviewing | Other | Approved | Medication Adherence | COMPLETED | NCT02823795 |
| interdisciplinary treatment | Drug | Preclinical | Chronic Pain | COMPLETED | NCT04598373 |
| Soured milk (filmjölk) | Other | Approved | Oxidative Stress | COMPLETED | NCT03821116 |
| Milk | Other | Approved | Oxidative Stress | COMPLETED | NCT03821116 |
| Placebo | Other | Phase PHASE2 | Atopic Dermatitis | COMPLETED | NCT04504279 |
| FB-401 | Other | Phase PHASE2 | Atopic Dermatitis | COMPLETED | NCT04504279 |
| FB-401 | Other | Phase PHASE2 | Atopic Dermatitis | TERMINATED | NCT04936113 |
| Child Centred Health Dialog (CCHD) | Other | Approved | Child, Only | COMPLETED | NCT04260672 |
| MINISTOP 2.0 | Other | Approved | Obesity, Childhood | COMPLETED | NCT04147039 |
| Quality Improvement Collaborative | Other | Approved | Contraception | UNKNOWN | NCT05521646 |
| Alcohol biomarker Phosphatidylethanol (PEth) | Other | Preclinical | Hypertension | UNKNOWN | NCT05580549 |
| No intervention | Other | Preclinical | Chronic Diseases in Children | ACTIVE_NOT_RECRUITING | NCT05809479 |
| Social prescribing in Sweden (SPiS) | Other | Approved | Loneliness | UNKNOWN | NCT04336553 |
| Navigator ACT group | Other | Approved | Parents | UNKNOWN | NCT05940168 |
| I-Navigator ACT | Other | Approved | Parents | UNKNOWN | NCT05940168 |
| Family Talk Intervention | Other | Approved | Terminal Illness | UNKNOWN | NCT05365919 |
| Rehabilitation as usual | Other | Approved | Stroke | COMPLETED | NCT04351178 |
| Mobile phone supported and team based rehabilitation | Other | Approved | Stroke | COMPLETED | NCT04351178 |
| Focus Group Interviews | Other | Preclinical | Mental Health Issue | ACTIVE_NOT_RECRUITING | NCT04465435 |
| Web-based self-report questionnaires | Other | Preclinical | Mental Health Issue | ACTIVE_NOT_RECRUITING | NCT04465435 |
| Make My Day - stroke prevention program | Other | Approved | Stroke | COMPLETED | NCT05279508 |
| Assist Reablement (including education and mentoring) | Other | Approved | Reablement | RECRUITING | NCT06749080 |
| Control Group | Other | Approved | Frailty | RECRUITING | NCT06368674 |
| Intervention group Case Manager (CM) | Other | Approved | Frailty | RECRUITING | NCT06368674 |
| Total contact cast | Other | Approved | Diabetic Foot | TERMINATED | NCT04085926 |
| Sealed therapeutic shoe | Other | Approved | Diabetic Foot | TERMINATED | NCT04085926 |
| Psychological treatment for persistent fatigue | Drug | Approved | Fatigue | COMPLETED | NCT06341751 |
| Health4Life app | Other | Approved | Healthy | RECRUITING | NCT06798597 |
| Placebo | Other | Phase PHASE2 | Celiac Disease | RECRUITING | NCT06982963 |
| FB102 | Other | Phase PHASE2 | Celiac Disease | RECRUITING | NCT06982963 |
| Endometriosis surgery | Procedure | Approved | Endometriosis | RECRUITING | NCT07240363 |
| Placebo | Other | Phase PHASE1 | Alopecia Areata | RECRUITING | NCT07205159 |
| FB102 | Other | Phase PHASE1 | Alopecia Areata | RECRUITING | NCT07205159 |
| Placebo | Other | Phase PHASE1 | Vitiligo | RECRUITING | NCT06905873 |
| FB102 | Other | Phase PHASE1 | Vitiligo | RECRUITING | NCT06905873 |
| Trauma-Focused Cognitive Behavioral Therapy (TF-CBT) | Drug | Approved | Post-traumatic Stress Disorder (PTSD) | RECRUITING | NCT07407946 |
| Blended Trauma-Focused Cognitive Behavioral Therapy with Compassion (bTF-CBT-C) | Drug | Approved | Post-traumatic Stress Disorder (PTSD) | RECRUITING | NCT07407946 |
| Safety Planning Intervention (SPI) | Other | Approved | Suicide Attempt | RECRUITING | NCT07469917 |
| Regular care transition | Other | Approved | Stroke | COMPLETED | NCT05646589 |
| Person-centred care transition support | Other | Approved | Stroke | COMPLETED | NCT05646589 |
| Brochure about falls and fall risk factors | Other | Approved | Multiple Sclerosis | COMPLETED | NCT04317716 |
| fall prevention program | Other | Approved | Multiple Sclerosis | COMPLETED | NCT04317716 |
| AFFEKT - a manual based brief parent program for parents of children (aged 6-12 years) with externalizing behaviors. | Other | Approved | Behavior, Child | COMPLETED | NCT05983705 |
| AFFEKT - a manual based brief parent program for parents of children (aged 6-12 years) with externalizing behaviors. | Other | Approved | Behavior, Child | COMPLETED | NCT05983705 |
| AFFEKT - a manual based brief parent program for parents of children (aged 6-12 years) with externalizing behaviors. | Other | Approved | Behavior, Child | COMPLETED | NCT05983705 |
| AFFEKT - a manual based brief parent program for parents of children (aged 6-12 years) with externalizing behaviors. | Other | Approved | Behavior, Child | COMPLETED | NCT05983705 |
| FB102 | DRUG | Phase PHASE1 | Alopecia Areata | RECRUITING | NCT07205159 |
| Placebo | DRUG | Phase PHASE1 | Alopecia Areata | RECRUITING | NCT07205159 |
| FB-401 | BIOLOGICAL | Phase PHASE2 | Atopic Dermatitis | TERMINATED | NCT04936113 |
Total products: 59